According to research, α-synuclein aggregates in cerebrospinal fluid (CSF) can be used as a biochemical diagnostic for the differential diagnosis of PD and are crucial for distinguishing PD from multisystem atrophy (Shahnawaz et al., 2020). The gene discussed is SNCA; the disease is multiple system atrophy.